Quantcast

Latest Onyx Pharmaceuticals Stories

2014-08-05 08:35:45

- Zalani joins Intarcia to drive the strategic and operational direction of Intarcia's Global Regulatory and Quality efforts with health authorities, partners and external stakeholders -

2014-07-07 08:22:14

-- Nexavar is the only approved treatment for patients with RAI-refractory differentiated thyroid cancer -- Nexavar significantly extended progression-free survival

2014-06-02 08:30:06

New Chief Medical Officer Brings Wealth of Experience in Innovative Therapies in Oncology SANTA MONICA, Calif., June 2, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biopharmaceutical

2014-05-06 16:32:39

SOUTH SAN FRANCISCO, May 6, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company's board of directors has elected Ted W.

2014-04-23 20:23:23

WHIPPANY, N.J. and THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., April 23, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.

2014-04-02 08:33:07

SAN DIEGO, April 2, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2014-03-31 23:37:07

Top Tier Panelists from Onyx Pharmaceuticals, BioMarin Pharmaceutical, San Francisco State University, and Clinovo Share Experience on How to Conduct Successful Outsourcing Strategies

2014-03-24 08:28:34

SAN DIEGO, March 24, 2014 /PRNewswire/ -- Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, today announced


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related